Burden of infectious diseases and bacterial antimicrobial resistance in China: a systematic analysis for the global burden of disease study 2019
The Lancet Regional Health - Western Pacific · 2024-02 · 43 · 100972
DOI: 10.1016/j.lanwpc.2023.100972 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Lancet Regional Health - Western Pacific, 2024-02. Verfasst von Chi Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease, Center for Liver Disease, Peking University First Hospital, Beijing, 100034, China. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Infectious diseases and antimicrobial resistance (AMR) has become pressing concerns in China. We aimed to comprehensively investigate the burden of them.
Methods
Data on infectious diseases and AMR were collected by the Global Antimicrobial Resistance Burden study 2019. Multinomial network meta-regression, logistic regression, and ensemble Spatiotemporal Gaussian process regression were used to fit the number and rate in DisMod-MR 2.1 modelling framework. We reported the number and rates of the disease burdens of 12 infectious syndromes by age and sex; described the burden caused by 43 pathogens; estimated the AMR burden of 22 bacteria and bacteria-antibiotics combinations.
Findings
There were an estimated 1.3 million (95% uncertainty intervals, UI 0.8-1.9) infection-related deaths, accounting for 12.1% of the total deaths in China 2019. Males were 1.5 times more affected than females. Bloodstream infections (BSIs) were most lethal infectious syndrome, associating with 521,392 deaths (286,307-870,583), followed by lower respiratory infections (373,175), and peritoneal and intra-abdominal infections (152,087). These five leading pathogens were S aureus, A baumannii, E coli, S pneumoniae, and E spp., which were associated with 41.2% (502,658/1,218,693) of all infection-related deaths. The pathogens of different infectious syndromes exhibited significant heterogeneity. In 2019, more than 600 thousand deaths were associated with AMR, including 145 thousand deaths attributable to AMR. The top 3 AMR attributable to death were carbapenems-resistance A baumannii (18,143), methicillin-resistance S aureus (16,933) and third-generation cephalosporins-resistance E coli (8032).
Interpretation
Infectious diseases and bacterial antimicrobial resistance were serious threat to public health in China, related to 1.3 million and more than 600 thousand deaths per-year, respectively. Antimicrobial stewardship was urgent. Funding: This work was supported by National Natural Science Foundation of China (82270626); China Mega-Project for Infectious Diseases (2017ZX10203202, 2013ZX10002005); the Project of Beijing Science and Technology Committee (Z191100007619037).
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Disease, Center for Liver Disease, Peking University First Hospital, Beijing, 100034, China.
- Department of Infectious Diseases, Peking University International Hospital, Beijing, 102206, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, C., Fu, X., Liu, Y., Zhao, H., & Wang, G. (2024). Burden of infectious diseases and bacterial antimicrobial resistance in China: a systematic analysis for the global burden of disease study 2019. The Lancet Regional Health - Western Pacific, 43, 100972. https://doi.org/10.1016/j.lanwpc.2023.100972
Vancouver
Zhang C, Fu X, Liu Y, Zhao H, Wang G. Burden of infectious diseases and bacterial antimicrobial resistance in China: a systematic analysis for the global burden of disease study 2019. The Lancet Regional Health - Western Pacific. 2024;43:100972. doi:10.1016/j.lanwpc.2023.100972
BibTeX
@article{Zhang2024,
author = {Zhang, Chi and Fu, Xinghuan and Liu, Yiqi and Zhao, Hong and Wang, Guiqiang},
title = {Burden of infectious diseases and bacterial antimicrobial resistance in China: a systematic analysis for the global burden of disease study 2019},
journal = {The Lancet Regional Health - Western Pacific},
year = {2024},
volume = {43},
pages = {100972},
doi = {10.1016/j.lanwpc.2023.100972}
}
EUVIMED